E-LIB Suche - Ergebnisse für: Satlin, Andrew

1

Adjunctive lumateperone (ITI‐007) in the treatment of bipol..:

Suppes, Trisha ; Durgam, Suresh ; Kozauer, Susan G....
Bipolar Disorders. 25 (2023) 6 - p. 478-488 , 2023

2

Safety and tolerability of lumateperone 42 mg: An open-labe..:

Correll, Christoph U. ; Vanover, Kimberly E. ; Davis, Robert E....
Schizophrenia Research. 228 (2021) - p. 198-205 , 2021

Link: https://doi.org/10.1016/..

3

Cardiometabolic Safety of Lumateperone (ITI−007): Post Hoc ..:

Edwards, John B. ; Satlin, Andrew ; Durgam, Suresh...
CNS Spectrums. 26 (2021) 2 - p. 152-152 , 2021

Link: https://doi.org/10.1017/..

4

Safety and tolerability of lumateperone for the treatment o..:

Kane, John M ; Durgam, Suresh ; Satlin, Andrew...
International Clinical Psychopharmacology. 36 (2021) 5 - p. 244-250 , 2021

Link: https://doi.org/10.1097/..

5

Lumateperone (ITI−007) in the Treatment of Bipolar Depressi..:

D'Souza, Ian ; Durgam, Suresh ; Satlin, Andrew...
CNS Spectrums. 26 (2021) 2 - p. 150-150 , 2021

Link: https://doi.org/10.1017/..

6

S221. THE EFFICACY OF LUMATEPERONE 42 MG IN THE TREATMENT O..:

Harvey, Philip D ; Satlin, Andrew ; Mates, Sharon...
Schizophrenia Bulletin. 46 (2020) Supplement_1 - p. S123-S123 , 2020

Link: https://doi.org/10.1093/..

7

M205. LONG-TERM SAFETY OF LUMATEPERONE (ITI-007): METABOLIC..:

Correll, Christoph ; Mates, Sharon ; Huo, Jason...
Schizophrenia Bulletin. 46 (2020) Supplement_1 - p. S214-S214 , 2020

Link: https://doi.org/10.1093/..

8

T205. LUMATEPERONE IN THE TREATMENT OF SCHIZOPHRENIA: EVALU..:

Kane, John M ; Mates, Sharon ; Vanover, Kimberly E...
Schizophrenia Bulletin. 46 (2020) Supplement_1 - p. S310-S310 , 2020

Link: https://doi.org/10.1093/..

9

186 Results From a 12-Month Open-label Safety Study of Luma..:

Correll, Christoph U. ; Vanover, Kimberly E ; Durgam, Suresh...
CNS Spectrums. 25 (2020) 2 - p. 317-318 , 2020

Link: https://doi.org/10.1017/..

10

Cardiac and Hemodynamic Effects of Acute Phosphodiesterase-..:

Gilotra, Nisha A. ; Devore, Adam ; Hays, Allison...
Journal of Cardiac Failure. 26 (2020) 10 - p. S12 , 2020

Link: https://doi.org/10.1016/..

11

185 The Safety and Tolerability of Lumateperone 42 mg for t..:

Kane, John M ; Vanover, Kimberly E ; Durgam, Suresh...
CNS Spectrums. 25 (2020) 2 - p. 316-317 , 2020

Link: https://doi.org/10.1017/..

12

Evaluation of long-term safety, tolerability, and behaviora..:

Arzimanoglou, Alexis ; Ferreira, Jose ; Satlin, Andrew...
European Journal of Paediatric Neurology. 23 (2019) 1 - p. 126-135 , 2019

Link: https://doi.org/10.1016/..

13

S117. FAVORABLE LONG-TERM SAFETY PROFILE OF LUMATEPERONE II..:

Vanover, Kimberly ; Satlin, Andrew ; Durgam, Saresh...
Schizophrenia Bulletin. 45 (2019) Supplement_2 - p. S351-S351 , 2019

Link: https://doi.org/10.1093/..

14

30 Lumateperone (ITI-007) for the Treatment of Schizophreni..:

Vanover, Kimberly ; Glass, Steven ; Kozauer, Susan...
CNS Spectrums. 24 (2019) 1 - p. 190-191 , 2019

Link: https://doi.org/10.1017/..

15

ITI-214, A Novel Phosphodiesterase I Inhibitor for the Trea..:

Davis, Robert ; Riesenberg, Robert ; Laskowitz, Daniel...
Neurology. 92 (2019) 15_supplement - p. , 2019

Link: https://doi.org/10.1212/..